$12.66
1.28% day before yesterday
Nasdaq, Oct 24, 10:01 pm CET
ISIN
US15687V1098
Symbol
CERT

Certara Stock price

$12.66
+1.20 10.47% 1M
-1.76 12.21% 6M
+2.01 18.87% YTD
+2.54 25.10% 1Y
+1.57 14.16% 3Y
-25.42 66.75% 5Y
-25.42 66.75% 10Y
-25.42 66.75% 20Y
Nasdaq, Closing price Fri, Oct 24 2025
+0.16 1.28%

Key metrics

Basic
Market capitalization
$2.0b
Enterprise Value
$2.2b
Net debt
$131.9m
Cash
$162.3m
Shares outstanding
160.6m
Valuation (TTM | estimate)
P/E
253.2 | 28.5
P/S
5.0 | 4.7
EV/Sales
5.3 | 5.0
EV/FCF
28.0
P/B
1.9
Financial Health
Equity Ratio
67.2%
Return on Equity
-1.1%
ROCE
1.8%
ROIC
1.4%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$405.8m | $430.2m
EBITDA
$81.3m | $134.5m
EBIT
$25.8m | $120.8m
Net Income
$8.0m | $71.3m
Free Cash Flow
$77.5m
Growth (TTM | estimate)
Revenue
11.6% | 11.7%
EBITDA
474.2% | 159.4%
EBIT
136.0% | 7,084.4%
Net Income
110.1% | 691.5%
Free Cash Flow
52.7%
Margin (TTM | estimate)
Gross
61.1%
EBITDA
20.0% | 31.3%
EBIT
6.4%
Net
2.0% | 16.6%
Free Cash Flow
19.1%
More
EPS
$0.1
FCF per Share
$0.5
Short interest
13.1%
Employees
2k
Rev per Employee
$250.0k
Show more

Is Certara a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,040 stocks worldwide.

Certara Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Certara forecast:

11x Buy
61%
7x Hold
39%

Analyst Opinions

18 Analysts have issued a Certara forecast:

Buy
61%
Hold
39%

Financial data from Certara

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
406 406
12% 12%
100%
- Direct Costs 158 158
6% 6%
39%
248 248
16% 16%
61%
- Selling and Administrative Expenses 131 131
13% 13%
32%
- Research and Development Expense 36 36
7% 7%
9%
81 81
474% 474%
20%
- Depreciation and Amortization 56 56
11% 11%
14%
EBIT (Operating Income) EBIT 26 26
136% 136%
6%
Net Profit 7.98 7.98
110% 110%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Certara directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Certara Stock News

Neutral
GlobeNewsWire
6 days ago
RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research.
Positive
Seeking Alpha
10 days ago
Certara posted strong Q1 and Q2 results, with revenue growth and non-GAAP EPS exceeding expectations, driven by biosimulation software and services. Certara's AI-enabled platforms, including the upcoming AI MIDD and CertaraIQ, are positioned as catalysts for sustainable, long-term growth in drug development. Despite a large total addressable market and cost control, Certara faces analyst downgr...
Neutral
GlobeNewsWire
16 days ago
RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
More Certara News

Company Profile

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.

Head office United States
CEO William Feehery
Employees 1,517
Founded 2008
Website www.certara.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today